<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00875719</url>
  </required_header>
  <id_info>
    <org_study_id>ANTADIR CMTS OXYGEN 2009</org_study_id>
    <nct_id>NCT00875719</nct_id>
  </id_info>
  <brief_title>Oxygen Portable Concentrator During Exercises in Patients With COPD</brief_title>
  <official_title>Comparing Effectiveness of Oxygen Supplementation From a Portable Concentrator and a Liquid Oxygen Source During Walking Test in COPD Patients With Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare differences in oxygen delivery between portable
      oxygen concentrators (POCs) and liquid oxygen (LOs) portable units, pose a question if POCs
      are equally effective as LOs in reducing exercise-induced hypoxaemia. DESIGN: Randomized,
      single-blind clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our primary objective is to compare at rest and during exercise the evolution of oxygen
      saturation and dyspnea during 6 minutes walking test in patients with COPD receiving oxygen
      supplementation either with portable concentrators or liquid oxygen in a random order.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Walking Distance</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>continuous v intermittent Oxygen therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intermittent oxygen compared to constant flow oxygen as regards walking distance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen concentrators versus constant flow axygen</intervention_name>
    <description>Each patient performed 2 walking tests, and received oxygen supplementation from a portable concentrator or a liquid oxygen source, in a random order.</description>
    <arm_group_label>continuous v intermittent Oxygen therapy</arm_group_label>
    <other_name>portable oxygen concentrator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>oxygen concentrator</intervention_name>
    <description>comparison walk distance and saturation with continuous oxygen compared to intermittent oxygen</description>
    <arm_group_label>continuous v intermittent Oxygen therapy</arm_group_label>
    <other_name>portable concentrator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD with respiratory failure and indication for oxygen supplementation at rest and/or
             during exercice.

        Exclusion Criteria:

          -  Evolutive heart disease.

          -  Unability to understand or realize the tests.

          -  Acute exacerbation during the last month.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris MELLONI, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Pneumologie et Allergologie- Hôpital le Cluzeau. 23 av. D. Larrey</name>
      <address>
        <city>LIMOGES cedex</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2009</study_first_submitted>
  <study_first_submitted_qc>April 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2009</study_first_posted>
  <last_update_submitted>February 15, 2011</last_update_submitted>
  <last_update_submitted_qc>February 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jean François MUIR - President</name_title>
    <organization>ANTADIR</organization>
  </responsible_party>
  <keyword>COPD patients with respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

